Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 5

Sebusuppressive efficacy of the antioxidant bis-ethylhexyl hydroxydimethoxy benzylmalonate in the treatment of oily and blemished skin

Authors Gerlach N, Graf, Witte, Lefort, Pfluecker, Heinrich U, Tronnier

Received 5 April 2012

Accepted for publication 24 May 2012

Published 20 August 2012 Volume 2012:5 Pages 101—109


Review by Single anonymous peer review

Peer reviewer comments 1

Nicole Gerlach,1 Ruediger Graf,2 Gabriele Witte,2 Marina Lefort,2 Frank Pfluecker,2 Ulrike Heinrich,1 Hagen Tronnier1

1DermaTronnier, University of Witten-Herdecke, Witten, Germany; 2Merck KGaA, Darmstadt, Germany

Abstract: The aim of this study was to assess the effect of 2% bis-ethylhexyl hydroxydimethoxy benzylmalonate (HDBM; RonaCare® AP) as an active ingredient in the treatment of oily and blemished skin. This study was carried out as a randomized, placebo-controlled, single-blind study on 44 test subjects with blemished skin over a period of 8 weeks. Sebum measurement, skin inflammation/redness scoring by an expert, photographic documentation and a self-assessment with regard to skin improvement, and tests of skin compatibility and galenic characteristics were performed. Treatment with 2% HDBM resulted in a significant reduction of sebum excretion and showed efficacy against inflamed/red lesions also shown by photographic documentation. Efficacy and galenic performance of 2% HDBM were judged to be superior to the placebo emulsion. Additionally, 2% HDBM was well tolerated; approximately 80% of the test subjects rated the compatibility as good to very good.

Keywords: oily and blemished skin, sebum excretion, antiseborrheic, anti-inflammatory, bis-ethylhexyl hydroxydimethoxy benzylmalonate (HDBM)

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]